Drug Index



Mechanism :

Doxapram hydrochloride produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. As the dosage is increased, the central respiratory centres in the medulla are stimulated with progressive stimulation of other parts of the brain and spinal cord. Increases minute volume and respiratory rate.

Indication :

• It is a central respiratory stimulant.

• Post anesthesia respiratory depression

• Drug induced CNS depression

Contraindications :

Doxapram is contraindicated in neonates due to its benzyl alcohol content. Doxapram should not be used in patients with epilepsy or other convulsive disorders and in patients with mechanical disorders of ventilation such as mechanical obstruction, muscle paresis, flail chest, pneumothorax, acute bronchial asthma, pulmonary fibrosis or other conditions resulting in restriction of chest wall, muscles of respiration or alveolar expansion. Doxapram is contraindicated in patients with evidence of head injury or cerebral vascular accident and in those with significant cardiovascular impairment, severe hypertension, or known hypersensitivity to the drug or any of the injection components.

Dosing :

<12 years: Safety and efficacy not established.

>12 years:

Post anesthesia respiratory depression:

IV infusion: 1-2 mg/min IV infusion for not more than 2 hours. Maximum dose: 3 mg/min. Watch for acidosis/CO2 retention.

IV intermittent dose: 0.5-1 mg/kg IV. Can be repeated at 5-min intervals. Maximum dose: 2 mg/kg.

Drug induced CNS depression:

1-2 mg/kg IV. Repeat in 1-2 hours. Maximum: 3 gm/day.

Adverse Effect :

Fever, sweating, itching, disorientation, dilated pupils, hallucinations, muscle spasticity, cough, bronchospasm, hypo-hyperventilation, arrhythmias, urinary retention, hemolysis, hypertension, anemia, leukopenia.

Interaction :

Sympathomimetic or Monoamine Oxidase Inhibiting drugs: May result in an additive pressor effect.
Muscle Relaxant Drugs: Doxapram may temporarily mask the residual effects of muscle relaxant drugs.
Volatile General Anaesthetics: Administration of doxapram should be delayed until the volatile agent has been excreted.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDUnlikely to be dialysed. Dose as in normal renal function
HDUnlikely to be dialysed. Dose as in normal renal function
HDF/High fluxUnlikely to be dialysed. Dose as in normal renal function
CAV/VVHDUnlikely to be dialysed. Dose as in normal renal function

Hepatic Dose :

There are no dosage adjustments provided in manufacturer's labeling (has not been studied); however, use caution in severe impairment due to the potential for altered pharmacokinetics.
07/28/2020 01:53:27 Doxapram
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0